GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CuraScientific Corp (OTCPK:CSTF) » Definitions » EV-to-EBITDA

CuraScientific (CuraScientific) EV-to-EBITDA : 0.04 (As of May. 12, 2024)


View and export this data going back to . Start your Free Trial

What is CuraScientific EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, CuraScientific's enterprise value is $1.45 Mil. CuraScientific's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was $33.91 Mil. Therefore, CuraScientific's EV-to-EBITDA for today is 0.04.

The historical rank and industry rank for CuraScientific's EV-to-EBITDA or its related term are showing as below:

CSTF' s EV-to-EBITDA Range Over the Past 10 Years
Min: -22.2   Med: -0.34   Max: 0.05
Current: 0.04

During the past 3 years, the highest EV-to-EBITDA of CuraScientific was 0.05. The lowest was -22.20. And the median was -0.34.

CSTF's EV-to-EBITDA is ranked better than
98.73% of 708 companies
in the Drug Manufacturers industry
Industry Median: 14.76 vs CSTF: 0.04

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-12), CuraScientific's stock price is $0.0002. CuraScientific's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was $0.027. Therefore, CuraScientific's PE Ratio for today is 0.01.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


CuraScientific EV-to-EBITDA Historical Data

The historical data trend for CuraScientific's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CuraScientific EV-to-EBITDA Chart

CuraScientific Annual Data
Trend Dec20 Dec21 Dec22
EV-to-EBITDA
-0.98 -0.58 -0.82

CuraScientific Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.36 -0.82 -14.09 0.04 0.12

Competitive Comparison of CuraScientific's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, CuraScientific's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CuraScientific's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CuraScientific's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where CuraScientific's EV-to-EBITDA falls into.



CuraScientific EV-to-EBITDA Calculation

CuraScientific's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=1.448/33.91
=0.04

CuraScientific's current Enterprise Value is $1.45 Mil.
CuraScientific's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $33.91 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CuraScientific  (OTCPK:CSTF) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

CuraScientific's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.0002/0.027
=0.01

CuraScientific's share price for today is $0.0002.
CuraScientific's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.027.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


CuraScientific EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of CuraScientific's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


CuraScientific (CuraScientific) Business Description

Traded in Other Exchanges
N/A
Address
51544 Cesar Chavez Street, Suite No. 1J, Coachella, CA, USA, 92236
CuraScientific Corp manufactures commercial chemicals with a variety of commercial sterilization applications for agriculture, warehousing, hospitality, and medical facilities. The company's product, DiOx+, is a disinfectant sterilizer that kills harmful pathogens without exposing people or the environment to dangerous toxins.
Executives
Paul Quentin Goyette director 2205 LOCH WAY, EL DORADO HILLS CA 95762
William Joseph Reed director, officer: Chief Executive Officer 333 N UNIVERSITY AVE., #33, REDLANDS CA 92374
Johann Loewen director C/O METHES ENERGIES INTERNATIONAL LTD, 3651 LINDELL ROAD, SUITE D-272, LAS VEGAS NV 89103
Edouard Maurice Beaudette director 13480 N BLOOMFIELD ROAD, NEVADA CITY CA 95959
Justin Michael Gonzalez director, officer: Chief Executive Officer 15723 LAKE VERA PURDON RD., NEVADA CITY CA 95959
Eric Jason Watson director, officer: Chief Operating Officer 19553 BOWERS DRIVE, TOPANGA CA 90290

CuraScientific (CuraScientific) Headlines

From GuruFocus

Introducing Leaf of Faith

By Marketwired Marketwired 03-26-2019